BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19531926)

  • 21. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan.
    Ma WL; Liu WD; Sun HY; Sheng WH; Hsieh SM; Wu SJ; Hung CC
    J Microbiol Immunol Infect; 2024 Jun; 57(3):426-436. PubMed ID: 38632022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
    Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
    Diamond C; Taylor TH; Im T; Anton-Culver H
    Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summaries for patients. Estimating outcome in patients with HIV-related lymphoma.
    Ann Intern Med; 2005 Aug; 143(4):I28. PubMed ID: 16103466
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Thiessard F; Morlat P; Marimoutou C; Labouyrie E; Ragnaud JM; Pellegrin JL; Dupon M; Dabis F
    Cancer; 2000 Apr; 88(7):1696-702. PubMed ID: 10738229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
    Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
    HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.
    Kirk O; Pedersen C; Cozzi-Lepri A; Antunes F; Miller V; Gatell JM; Katlama C; Lazzarin A; Skinhøj P; Barton SE;
    Blood; 2001 Dec; 98(12):3406-12. PubMed ID: 11719381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
    Antinori A; Cingolani A; Alba L; Ammassari A; Serraino D; Ciancio BC; Palmieri F; De Luca A; Larocca LM; Ruco L; Ippolito G; Cauda R
    AIDS; 2001 Aug; 15(12):1483-91. PubMed ID: 11504980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
    Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G
    Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
    Bhaskaran K; Brettle R; Porter K; Walker AS;
    AIDS; 2004 Mar; 18(4):673-81. PubMed ID: 15090773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Wang Q; De Luca A; Smith C; Zangerle R; Sambatakou H; Bonnet F; Smit C; Schommers P; Thornton A; Berenguer J; Peters L; Spagnuolo V; Ammassari A; Antinori A; Quiros-Roldan E; Mussini C; Miro JM; Konopnicki D; Fehr J; Campbell MA; Termote M; Bucher HC;
    Ann Intern Med; 2017 Jan; 166(1):9-17. PubMed ID: 27750294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-Hodgkin lymphomas with systemic presentation in patients with HIV infection. Clinical and prognostic factors in a series evaluated before the introduction of the highly active antiretroviral therapy (HAART)].
    Segura Huerta A; López Tendero P; Romera Barroso B; Yuste Izquierdo AL; Gironés Sarrió R; Pérez Fidalgo JA; Gómez Codina J; López Aldeguer J
    Rev Clin Esp; 2004 Jun; 204(6):303-7. PubMed ID: 15171891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010.
    Gopal S; Martin KE; Richards KL; Eron JJ
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):798-805. PubMed ID: 22011066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
    Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP
    J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.
    Engels EA; Pfeiffer RM; Landgren O; Moore RD
    J Acquir Immune Defic Syndr; 2010 May; 54(1):78-84. PubMed ID: 20418723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
    Castelli R; Schiavon R; Preti C; Ferraris L
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.